• HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques
• HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies
• HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
• HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies

Pre-proposal

• HORIZON-HLTH-2025-03-DISEASE-02- two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders

• HORIZON-CL2-2025-01-HERITAGE-09: Impacts of culture and the arts on health and well-being

• HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
• HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibodyderived proteins for the prevention and treatment of infectious diseases with epidemic potential
• HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response
• HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
• HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable highquality care and health outcomes in the context of non-communicable diseases (GACD)
• HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and underresearched medical conditions

Pre-proposal

• HORIZON-HLTH-2025-03-STAYHLTH-01- two-stage: Improving the quality of life of persons with intellectual disabilities and their families

• HORIZON-CL6-2025-02-FARM2FORK-12: Nutrition and Mental Health

The purpose of this call is to support the provision and development of educational content for healthcare professionals on the implementation of personalised medicine.

• HORIZON-MISS-2025-06-CIT-CANCER-01: Increasing walking and cycling: to reap health benefits, emission reductions and integrate active mobility and micro-mobility devices, with smart technologies and infrastructure

• HORIZON-HLTH-2025-02- DISEASE-01: European Partnership for Brain Health
• HORIZON-HLTH-2025-02- DISEASE-02: European partnership fostering a European Research Area (ERA) for health research (Phase 2)

This call for tenders aims to speed up the development of next generation influenza vaccines. The call will be implemented via a competitive development in phases as foreseen under Pre-Commercial Procurement.

This call for tenders aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility results on the bacteria or fungi causing an infection in humans, within one hour or less from subject sample collection, and ideally, to also allow for pathogen identification. By the end of the contract, the product developed should aim at reaching system complete and qualified (TRL 8). 

IHI call 10 will be a standard, two-stage call for proposals with the following topics:

• Digital label: one source of comprehensive information for medical technology products
• Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
• Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector

HI call 9 will be a single-stage, applicant driven call with five topics aligned with the five specific objectives set out in the IHI Strategic Research and Innovation Agenda (SRIA). For this call, we want applicants to explore the SRIA and identify untapped opportunities that could be transformed into public-private projects through IHI. Read the draft call 9 text.

The objective of this call for tender is to strengthen the scientific evidence on the immune response provided by the Modified Vaccinia Ankara virus-Bavarian Nordic (MVA-BN) vaccine, with particular emphasis on the need and optimal timing of booster doses.

EDCTP3 calls 2025 (pre-proposals):

• Vaccines for reducing the disease burden of tuberculosis in sub-Saharan Africa
• Malaria therapeutics and clinical development of new antimalarial candidates (RIA)
• Accelerating the development of prophylactic vaccines against neglected tropical diseases (RIA)
• Strategic training hubs for fellowships in public health (CSA)
• Strengthening the regional networks of excellence and epidemic preparedness consortia (CSA)
• Tackling diarrhoeal diseases in the context of climate and health transformative innovations (RIA)
• Transformative innovations in global health (RIA)

 See the Q&A Global Health EDCTP3 – WP 2025